Sweden - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingSweden: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Sweden
In 2021, after four years of growth, there was significant decline in the Swedish market for hormones, prostaglandins, thromboxanes and leukotrienes, when its value decreased by -35.3% to $X. Overall, the total consumption indicated tangible growth from 2012 to 2021: its value increased at an average annual rate of +3.2% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Hormones, prostaglandins, thromboxanes and leukotrienes consumption peaked at $X in 2020, and then contracted remarkably in the following year.
Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Sweden
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production dropped significantly to $X in 2021 estimated in export price. Over the period under review, production continues to indicate a deep reduction. The pace of growth was the most pronounced in 2019 when the production volume increased by 32%. Over the period under review, production reached the peak level at $X in 2012; however, from 2013 to 2021, production remained at a lower figure.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports from Sweden
In 2021, shipments abroad of hormones, prostaglandins, thromboxanes and leukotrienes increased by 28% to X tons, rising for the third consecutive year after two years of decline. Overall, total exports indicated strong growth from 2012 to 2021: its volume increased at an average annual rate of +5.0% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +92.7% against 2018 indices. The pace of growth was the most pronounced in 2015 with an increase of 38%. Over the period under review, the exports attained the peak figure in 2021 and are expected to retain growth in years to come.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports shrank markedly to $X in 2021. In general, exports, however, saw a abrupt contraction. The pace of growth was the most pronounced in 2019 when exports increased by 14%. Over the period under review, the exports attained the maximum at $X in 2013; however, from 2014 to 2021, the exports stood at a somewhat lower figure.
Exports by Country
Ireland (X tons) was the main destination for hormones, prostaglandins, thromboxanes and leukotrienes exports from Sweden, accounting for a 67% share of total exports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes exports to Ireland exceeded the volume sent to the second major destination, the United States (X tons), fourfold. Belgium (X kg) ranked third in terms of total exports with a 5.6% share.
From 2012 to 2021, the average annual rate of growth in terms of volume to Ireland stood at +4.4%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (+11.0% per year) and Belgium (-5.9% per year).
In value terms, Belgium ($X), Germany ($X) and the United States ($X) appeared to be the largest markets for hormones, prostaglandins, thromboxanes and leukotrienes exported from Sweden worldwide, with a combined 83% share of total exports.
Germany, with a CAGR of +25.1%, saw the highest rates of growth with regard to the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced a decline.
Export Prices by Country
The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, waning by -54.8% against the previous year. In general, the export price recorded a abrupt shrinkage. The growth pace was the most rapid in 2013 when the average export price increased by 40%. As a result, the export price reached the peak level of $X per kg. From 2014 to 2021, the average export prices remained at a somewhat lower figure.
Prices varied noticeably country of destination: the country with the highest price was Australia ($X per kg), while the average price for exports to Ireland ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Germany (+0.5%), while the prices for the other major destinations experienced a decline.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports into Sweden
In 2021, hormones, prostaglandins, thromboxanes and leukotrienes imports into Sweden dropped sharply to X tons, shrinking by -53.3% compared with 2020 figures. Overall, imports showed a mild decrease. The growth pace was the most rapid in 2020 when imports increased by 150%. As a result, imports reached the peak of X tons, and then fell rapidly in the following year.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports declined significantly to $X in 2021. In general, imports, however, showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2020 with an increase of 99.9%. Over the period under review, imports hit record highs at $X in 2014; however, from 2015 to 2021, imports failed to regain momentum.
Imports by Country
In 2021, France (X tons) constituted the largest supplier of hormones, prostaglandins, thromboxanes and leukotrienes to Sweden, accounting for a 57% share of total imports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes imports from France exceeded the figures recorded by the second-largest supplier, the Netherlands (X tons), twofold. The United States (X kg) ranked third in terms of total imports with a 6.6% share.
From 2012 to 2021, the average annual rate of growth in terms of volume from France totaled -3.1%. The remaining supplying countries recorded the following average annual rates of imports growth: the Netherlands (+9.6% per year) and the United States (-7.6% per year).
In value terms, the largest hormones, prostaglandins, thromboxanes and leukotrienes suppliers to Sweden were France ($X), the Netherlands ($X) and Germany ($X), with a combined 88% share of total imports. The United States, Denmark, the Czech Republic, Austria and Belgium lagged somewhat behind, together accounting for a further 5.2%.
The Czech Republic, with a CAGR of +71.5%, saw the highest rates of growth with regard to the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2021, the average import price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X per kg, increasing by 29% against the previous year. Over the period under review, import price indicated a slight increase from 2012 to 2021: its price increased at an average annual rate of +1.3% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2014 when the average import price increased by 76%. As a result, import price attained the peak level of $X per kg. From 2015 to 2021, the average import prices failed to regain momentum.
Prices varied noticeably country of origin: the country with the highest price was Germany ($X per kg), while the price for Belgium ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the Czech Republic (+11.7%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Sweden. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21105200 - Hormones, prostaglandins, thromboxanes and leukotrienes, n atural or reproduced by synthesis, derivatives and structural analogues thereof, including chain modified polypeptides, u sed primarily as hormones
Country coverage:
- Sweden
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Sweden
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.